Red Light Holland’s investment through the expected acquisition of Mera Life Sciences would enable global expansion and create a major scientific research and development division to explore plant-based remedies and treatment clinics in the Caribbean
December 30, 2020 (Source) — Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTC: TRUFF) (“Red Light Holland” or the “Company“), is pleased to announce it has entered into a non-binding letter of intent to acquire 100% of Mera Life Sciences LLC (“Mera“), a company focused on developing a modern medicinal industry in St Vincent and the Grenadines, with their issued Psychedelic Licenses, which includes the following plants and compounds (the “Compounds”): (i) Mushrooms/Truffles – Psilocybin; (ii) Ketamine; (iii) Ayahuasca; (iv) 3,4-Methylenedioxymethamphetamine (MDMA); (v) 5-methoxy-N,N-dimethyltryptamine (5-MEO-DMT); (vi) Dimethyltryptamine (DMT); (vii) Sassafras; (viii) Ibogaine; (ix) Peyote (x) Papaya; (xi) Aloe Vera; (xii) Arrowroot; (xiii) Soursop; (xiv) Ginger; (xv) Moringa; and (xvi) Coconut Oil.
“The acquisition of Mera and its coveted licenses would allow Red Light Holland to perform high quality psychedelic product research and development, cultivate, extract and process, and export not just Psilocybin, but with compounds such as Ayahuasca, MDMA, DMT, Peyote, Ketamine and many other natural based plants as well. We are The People’s Company and we want to work closely with countries wishing to develop plant and fungus-based remedies – including treatment clinics, and we now understand that St. Vincent and the Grenadines shares our vision.” said Todd Shapiro, CEO and Director of Red Light Holland.
As well, the terms of the agreement will permit Red Light Holland to collaborate with Vincentian entities to import any of the above Compounds.
“The opportunity to explore the inner molecular worlds of multiple plant species, including a variety of psychedelics, is an exciting one. This could put Red Light Holland in the position to discover novel clinical applications for a variety of natural psychedelics. By utilizing a lab built for this purpose on the (main) island, along with cutting edge artificial intelligence, something I’m very familiar with, Red Light Holland would be approaching the frontier of natural plant based drug discovery,” said Dr. Joseph Geraci, Scientific Advisor of Red Light Holland and CEO of NetraMark Corp.
“Red Light Holland is focused on establishing itself as a multi country operator with natural plants and natural fungi, from growing to distribution of legal sales to potential clinics. We look forward to the careful due diligence process and hopefully adding Mera and their ground-breaking licenses in SVG, which would instantly strengthen our Scientific and Innovation Division, Scarlette Lillie by expanding our vision for research and development and for providing access to natural psychedelics on all fronts,” added Shapiro.